Remove 2024 Remove Competition Remove Safety Remove Training
article thumbnail

Vaxcyte trains its sight on a lucrative market with pneumococcal vaccine

Pharmaceutical Technology

The vaccine demonstrated a similar safety profile to Pfizer’s marketed 20-serotype shot Prevnar 20 at all assessed doses, and showed non-inferior efficacy. There, the business plans to submit an IND application for a Phase I/II in the second half of 2023, with a readout in 2024. Competition in an increasingly heated market.

article thumbnail

What Regulations Need to Be Put in Place to Ensure the Safe Use of AI in the U.S.?

PM360

Even top AI developers from Google and OpenAI co-signed a statement at the end of May from non-profit the Center for AI Safety that said, “Mitigating the risk of extinction from AI should be a global priority alongside other societal-scale risks such as pandemics and nuclear war.”

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

European Health Data Space (EHDS) update: what this means for pharmaceutical and biotech

pharmaphorum

It has been proposed that the amount of these fees charged by the data holder must be transparent, proportionate, and “must not restrict competition” 10. The EC is hoping that, by the end of its current mandate on 31 October 2024, the legislative process will be completed, with the EHDS becoming operational in 2025.

article thumbnail

How To Get A Job In Orthopedic Medical Device Sales With Joey Testa & Travis Harvey

Evolve Your Success

Travis Harvey was a training pilot, and what I mean by that is Joey wanted to see if he took on a young man who wanted to make his way in the industry. One thing that is not talked about enough, and I’m going to have some guests on here in 2024, is that there are a lot of people who get into this space and then quit 5 or 6 months in.

Sales 52